PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM HEALTH ECONOMIC ANALYSIS
Abstract
Authors
JL Palmer CG Pinto R Duarte L Miguel Z Gregor